Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalInterest income - LoansInvestment Banking IncomeNet Income towards Common StockholdersNon Operating IncomeNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

MetroCity Bankshares (MCBS) Research & Development (2018 - 2025)

MetroCity Bankshares (MCBS) has disclosed Research & Development for 7 consecutive years, with $394000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development rose 26.69% to $394000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 9.62% increase, with the full-year FY2021 number at $1.1 million, up 2.04% from a year prior.
  • Research & Development was $394000.0 for Q3 2025 at MetroCity Bankshares, up from $329000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $394000.0 in Q3 2025 to a low of $252000.0 in Q4 2021.
  • A 5-year average of $303875.0 and a median of $297000.0 in 2023 define the central range for Research & Development.
  • Biggest YoY gain for Research & Development was 40.8% in 2021; the steepest drop was 19.49% in 2021.
  • MetroCity Bankshares' Research & Development stood at $252000.0 in 2021, then increased by 7.14% to $270000.0 in 2022, then rose by 11.11% to $300000.0 in 2023, then grew by 3.67% to $311000.0 in 2024, then rose by 26.69% to $394000.0 in 2025.
  • Per Business Quant, the three most recent readings for MCBS's Research & Development are $394000.0 (Q3 2025), $329000.0 (Q2 2025), and $345000.0 (Q1 2025).